![Christopher Ehrlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Ehrlich
Fondateur chez
Prostate Management Diagnostics Inc.
Fortune : 32 $ au 30/06/2026
Profil
Christopher B. Ehrlich is the founder of Prostate Management Diagnostics Inc., founded in 2012, serving as Director since its founding.
Mr. Ehrlich is also the founder of AlgoRx Pharmaceuticals, Inc...
Current positions include Chief Executive Officer & Director at Launch One Acquisition Corp.
since 2024; Chairman & Chief Executive Officer at CERo Therapeutics Holdings, Inc. since 2024; Chief Executive Officer at CERo Therapeutics, Inc. since 2024; Director at QuatRx Pharmaceuticals Co. since 2004; and Director at Prolynx LLC since 2022.
Former positions include Chief Executive Officer at Locust Walk Acquisition Corp.
from 2021 to 2022; Chief Executive Officer & Director at Phoenix Biotech Acquisition Corp.
from 2021 to 2024; Director-Business Development at Genentech, Inc. in 1997; Director at KAI Pharmaceuticals, Inc.; Director at BioMimetic Therapeutics, Inc. from 2004 to 2013; Director at Satori Pharmaceuticals, Inc.; Director at Carbylan Therapeutics, Inc.; Director at Invuity, Inc.; Director at Solace Pharmaceuticals, Inc.; Independent Director at eFFECTOR Therapeutics, Inc. from 2022 to 2024; Director at Xenon Pharmaceuticals, Inc.; Director-Licensing & Business Development at Purdue Pharma LP from 1998 to 1999; Director-Biotechnology Strategy Development at The Lek from 1992 to 1994; Director at CVRx, Inc.; Director-Venture Capital at The U.S.
Russia Investment Fund LLC from 1994 to 1996; Director at Follica, Inc.; Independent Director at Transcept Pharma, Inc. from 2011 to 2013; Managing Director & General Partner at InterWest Venture Management Co. from 2000 to 2013; Senior MD & Head-Global Biotechnology at Locust Walk Partners LLC from 2013 to 2021.
Education includes an undergraduate degree from Dartmouth College conferred in 1992 and an MBAistration from Kellogg School of Management conferred in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01 % | 28/04/2026 | 2 900 ( 0,01 % ) | 32 $ | 30/06/2026 |
Postes actifs de Christopher Ehrlich
| Sociétés | Poste | Début |
|---|---|---|
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutic compounds | Directeur/Membre du Conseil | 01/10/2004 |
Prostate Management Diagnostics Inc.
 Prostate Management Diagnostics Inc. BiotechnologyHealth Technology Provides research and test of fluid-based screening tool | Fondateur | 01/01/2012 |
Prolynx LLC
 Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Provides biological research services | Directeur/Membre du Conseil | 20/09/2022 |
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Directeur Général | 09/12/2024 |
Anciens postes connus de Christopher Ehrlich
| Sociétés | Poste | Fin |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/06/2024 |
Phoenix Biotech Acquisition Corp.
 Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur Général | 01/02/2024 |
| EFFECTOR THERAPEUTICS, INC. | Directeur Général | 01/01/2022 |
Locust Walk Partners LLC
 Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides commercial supporting and advisory services | Corporate Officer/Principal | 01/01/2021 |
| INVUITY INC | Directeur/Membre du Conseil | 01/01/2018 |
Formation de Christopher Ehrlich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutic compounds | Health Technology |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
BioMimetic Therapeutics, Inc.
 BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells protein therapeutics for tissue and organ regeneration | Health Technology |
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Health Technology |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Invuity, Inc.
 Invuity, Inc. Medical SpecialtiesHealth Technology Develops medical devices surgical field applications | Health Technology |
Solace Pharmaceuticals, Inc.
 Solace Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for treatment of neuropathic pain | Health Technology |
Prostate Management Diagnostics Inc.
Prostate Management Diagnostics Inc. BiotechnologyHealth Technology Provides research and test of fluid-based screening tool | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for pain management | Health Technology |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
CVRx, Inc.
 CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
The US Russia Investment Fund
 The US Russia Investment Fund Investment ManagersFinance Acts as Private Equity Fund | Finance |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Develops therapies for hair follicle disorders | Consumer Services |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides commercial supporting and advisory services | Commercial Services |
Interwest Venture Management Co.
 Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Finance |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prolynx LLC
Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Provides biological research services | Commercial Services |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Health Technology |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
